Ignite Creation Date:
2024-05-05 @ 11:46 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00120796
Status:
TERMINATED
Last Update Posted:
2016-07-21
First Post:
2005-07-12
Brief Title:
Lamivudine and Therapeutic Vaccine Evaluation in Senegalese Patients With Chronic Hepatitis B Infection ANRS 12100 HEPADAK-2
Sponsor:
French National Agency for Research on AIDS and Viral Hepatitis
Organization:
ANRS Emerging Infectious Diseases
Organization Data
Organization:
ANRS Emerging Infectious Diseases
Class:
OTHER_GOV
Study ID:
ANRS 12100 HEPADAK-2
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
French National Agency for Research on AIDS and Viral Hepatitis
Lead Sponsor Class:
OTHER_GOV
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Director
Old Organization:
ANRS
Collaborators
| Name | Class |
|---|---|
| GlaxoSmithKline | INDUSTRY |